Drug intelligence / Profile preview

vecuronium + atracurium

Development stage
Unknown
Lead developer
Organon
Modality
Small Molecules
Administration
Intravenous
01

Overview

A combination of two non-depolarizing neuromuscular blocking agents used in anesthesia as an adjunct to general anesthesia to facilitate endotracheal intubation and provide skeletal muscle relaxation during surgery or mechanical ventilation. The combination demonstrates synergistic (supra-additive) effects, with studies showing a longer duration of neuromuscular blockade than would be expected from simple additivity of the individual drugs. It has been investigated for facilitating endotracheal intubation, particularly when succinylcholine is contraindicated. Half-dose combinations have been shown to provide excellent intubating conditions. While onset time findings vary, the combination generally results in a longer duration of action compared to either drug alone. The synergistic effect allows for reduced dosages of each drug while maintaining efficacy. Hemodynamic stability appears similar to vecuronium alone.

Other names
FID123300 + FID123301
02

Targets

Muscle-type nicotinic acetylcholine receptorα3β2 nAChR (α3β2 nicotinic receptor)CHRNA7 (α7 nicotinic receptor)

Beyond the preview

Go deeper on vecuronium + atracurium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on vecuronium + atracurium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call